A report has been submitted to the U. S. Food and Drug Administration regarding the blockage problems caused by generic acid reflux drug in oral syringe or feeding tubes.

This drug is made by Teva Pharmaceutical Industries Ltd. This may cause acute problems to the patients.

The FDA has recommended the prohibition of manufacturers of the latest version of orally disintegrate tablet (ODT) form of lansoprazole through oral syringes or feeding tubes and also suggest patients to avoid using such tablets.

All the new version is manufactured by Israel- based Teva. Surprisingly not a single problem was detected by the patients who took the product by mouth.

Receiving such reactions Teva willingly quitted its version of the drug from distribution.

In addition, the FDA has given a warning on its website that there are possibilities that some stock may remain with pharmacies, other facilities or may be with the patients consuming it.

Lansoprazole is common version of Takeda pharmaceutical Co's Prevacid. Proton pump inhibitors is the category of drugs which is broadly used and Lansoprazole is the member of this class.

The benefit of the taking this drug is that it prevents acid reflux and treats ulcers.